Siriuspoint Ltd Stock Price, News & Analysis

SiriusPoint (NYSE: SPNT) announced a quarterly cash dividend of $0.50 per share on its 8.00% Resettable Fixed Rate Preference Shares, Series B ($0.10 par, $25.00 liquidation preference).

The dividend is payable on or prior to November 28, 2025 to Series B shareholders of record as of November 13, 2025. The payment was approved by the Audit Committee of the Board of Directors.

SiriusPoint (NYSE:SPNT)Core combined ratio of 89.1% and underwriting income of $69.6 million in Q3. Gross premiums written for Core rose 26% year‑over‑year to $871.6 million in the quarter. Quarterly operating return on equity was 17.9% (annualized) and year‑to‑date operating ROE was 16.1%, both above the company’s 12–15% target range. Book value per diluted common share (ex. AOCI) rose 5.3% quarter over quarter to $16.47. Nine‑month catastrophe losses were $67.4 million, primarily from California wildfires.

SiriusPoint (NYSE: SPNT) announced that Will Nihan will become Chief Executive Officer of International Medical Group (IMG), its wholly owned subsidiary, effective 3 November 2025. Nihan joins from Travelex Insurance Services, where he served as President and CEO and is credited with driving top-line growth and improved profitability. His prior roles include North America Head of Sales and Distribution at Zurich Global Ventures and senior marketing roles at Prudential and AIG. Nihan replaces Adam Hirschfeld, who served as Interim CEO since March 2025 and will remain on IMG’s executive team to support the transition and IMG’s growth and transformation.

SiriusPoint (NYSE: SPNT) will release its third quarter 2025 financial results after market close on Thursday, October 30, 2025. The company will host a conference call with Q&A at 8:30 AM ET on Friday, October 31, 2025. Investors can access a live webcast via the Investor Relations section at www.siriuspt.com and an online replay immediately after the call.

Telephone access: 1-877-451-6152 (U.S.) or 1-201-389-0879 (international). Replay available until 11:59 PM ET on November 14, 2025 via dial-in with passcode 13755914.

SiriusPoint (NYSE: SPNT) announced on Oct 6, 2025 the sale of its 49% equity stake in Arcadian MGA to Lee Equity Partners for $139 million (inclusive of a pre-close dividend). The company said it will recognize a $25–30 million pre-tax gain on completion, in addition to a $96 million gain recorded in Q2 2024. The press release states SiriusPoint renewed and extended its capacity agreement with Arcadian through end-2031. Arcadian reported $17.6 million EBITDA (per the PR). Closing is expected before Q1 2026, subject to regulatory approvals and customary conditions.

SiriusPoint (NYSE:SPNT) received a significant boost as S&P Global Ratings revised its outlook to Positive from Stable, while affirming the company's 'A-' issuer credit and financial strength ratings for core operating subsidiaries and 'BBB' long-term issuer credit rating.

The improved outlook stems from SiriusPoint's strong underwriting profits over the past 2.5 years and significantly reduced risk profile, particularly in natural catastrophe and investment exposure. Notably, all three major rating agencies - S&P, Fitch, and AM Best - have now revised SiriusPoint's outlook to Positive in 2025, highlighting the company's successful strategy in risk reduction, underwriting excellence, and disciplined investment approach.

Ambac Financial Group (NYSE: AMBC) has announced the acquisition of ArmadaCare from SiriusPoint for $250 million. ArmadaCare, headquartered in Hunt Valley, Maryland, is a leading supplemental health insurance program manager specializing in innovative workplace benefit products.

The transaction will be financed through a combination of cash and new debt, including a $120 million commitment from Truist Bank. The deal is expected to close in Q4 2025 and become accretive to shareholders by 2026. ArmadaCare's current CEO Ed Walker will continue leading the health insurance business with his management team.

This strategic acquisition follows Ambac's transformation into a pure-play MGA and specialty insurance platform, strengthening its market position and accelerating its specialty insurance distribution strategy.

SiriusPoint (NYSE: SPNT) has agreed to sell ArmadaCare, its supplemental health insurance program manager, to Ambac Financial Group for $250 million. The transaction values Armada at approximately 14x EBITDA and is expected to generate a pre-tax gain of $220-230 million for SiriusPoint.

While divesting its equity stake, SiriusPoint will maintain a capacity partnership with Armada through 2030. The deal is anticipated to increase pro-forma tangible book value by 10% upon closing in Q4 2025. The company maintains its across-the-cycle target return on equity of 12% to 15% and continues to see growth opportunities in its Accident & Health segment, including through its International Medical Group platform.

SiriusPoint (NYSE:SPNT), a global specialty insurer and reinsurer, has appointed Martin Hudson as Board Director, effective September 1, 2025. Hudson brings over 40 years of international (re)insurance leadership experience in underwriting, risk management, governance, and executive management.

Hudson currently serves as Independent Non-Executive Director at Liberty Mutual Managing Agency Ltd and Liberty Mutual Insurance Europe SE. His extensive career includes senior executive positions at Travelers Insurance, Mitsui Sumitomo Insurance Group, and Old Mutual Specialty Insurance, with experience spanning the US, UK, Europe, Canada, and Asia.